On 4 Oct, the MORU Malaria Dept, in collaboration with the Global Sepsis Alliance (GSA), hosted the inaugural meeting of a proposed Asian Sepsis Alliance in Bangkok. The meeting drew intensive care and infectious disease physicians from 9 Asian-Pacific countries (Thailand, Pakistan, India, Sri Lanka, Bangladesh, Malaysia, Singapore, China and Australia). GSA heads Profs Konrad Reinhart, Simon Finfer and Flavia Machado also attended, ...
11 Sept 2018 – Dr Myo Maung Maung Swe (left), Clinical Researcher and DPhil student at MOCRU, was awarded in August an International Society for Infectious Diseases (ISID) research grant, a signature ISID program that funds infectious disease researchers from LMIC countries with the greatest burden of infectious disease. Myo Maung, a clinical researcher at MOCRU for 3 years, was awarded the ISID research grant to conduct the study Antibiotics ...
ROME (Thomson Reuters Foundation) - In his first 12 years working as a vet in Bangladesh, Bikash Chandra Saha routinely prescribed antibiotics. Then he learned of the devastating impact of antimicrobial resistance on human health - and it revolutionized his treatment choices. More information
Bangkok / Oxford, 22 August 2018 – The economic costs of antimicrobial resistance (AMR) for every course of antibiotics are considerable, and much higher than their purchase cost, say researchers. In a landmark study, a team of researchers led by the Mahidol Oxford Research Centre (MORU) and the Infectious Diseases Data Observatory (IDDO) used data from the USA and Thailand to link the consumption of antibiotics with the direct and indirect ...
A fun and exciting way to meet scientists and hear about the amazing work that goes on in the world of science! Join us for a one-night-only special at WeLearn, 2nd floor Maneeya Centre, 518/4 Ploenchit Road, on the 23rd August 2018 7-9pm (doors open at 6.30pm)
Scientists are racing to stamp out the disease in Southeast Asia before unstoppable strains spread. This article features MORU, SMRU and colleagues, and explains what is happening and what we are doing to eliminate drug-resistant malaria in Southeast Asia before it spreads.
Infections such as dengue and Japanese encephalitis are important problems in Laos but confirmed data are lacking, particularly from outside the capital Vientiane. Rapid diagnostic tests that can be kept at tropical room temperature help better diagnosis and treatment, and also inform policy to implement vaccination programmes.
Scrub typhus is an infection caused by Orientia tsutsugamushi, a bacteria transmitted by the bite of an infected chigger mite. Characterised by a variety of symptoms and a high mortality rate, scrub typhus is an underfunded, neglected tropical disease not even listed by the WHO. Better diagnostic tests and optimised treatments are being developed since no vaccine is currently available.
Genomics is the study of the complete DNA sequence, for example of a particular parasite, allowing us to analyse its evolution and the impact of human interventions. Alongside clinical date, we use genomics to identify mutations that are markers for drug resistance. Mapping out drug resistance then helps inform elimination programmes.
Anti-malaria drug resistance is spreading throughout Southeast Asia and we need to find new treatments. Our researchers at MORU use a combination of artemisinin and two partner drugs instead of one. If confirmed safe and tolerable, triple artemisinin combination therapies might be a good option to treat multi-drug resistant malaria, as well as slow down the emergence and spread of anti-malarial resistance.